id: Q8IX29
gene_symbol: FBXO16
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  FBXO16 (F-box only protein 16) is an F-box "other" (FBXO) family protein that
  serves as the substrate-recognition component of an SCF (SKP1-CUL1-F-box
  protein) / CRL1 Cullin-RING E3 ubiquitin-protein ligase complex. Through its
  F-box domain (residues 86-132) it docks onto SKP1 within the SCF scaffold,
  while its C-terminal region recruits specific substrate proteins for
  ubiquitination and subsequent proteasomal degradation; the catalytic transfer
  of ubiquitin is performed by the RING subunit RBX1 and an E2 enzyme, not by
  FBXO16 itself; consistently, its F-box domain is required for assembling a
  functional ligase complex while its C-terminal region mediates substrate
  recognition (e.g. binding the RRM3 domain of hnRNPL and the C-terminus being
  essential for beta-catenin binding). FBXO16 acts predominantly in the nucleus
  and drives K48-linked polyubiquitination of its targets. Reported substrates
  include the nuclear pool of beta-catenin/CTNNB1 (suppressing Wnt/TCF output such
  as c-Myc and Cyclin D1), the RNA-binding protein hnRNPL (whose degradation
  restrains MAPK/RAS/Wnt outputs), the autophagy-initiating kinase ULK1 (K48-linked
  polyubiquitination, suppressing autophagy), and the NF-kappa-B subunit RELA/p65
  (as the substrate-recognition component of a PDLIM2-containing CRL1 complex that
  degrades nuclear p65). Through these targets FBXO16 has been implicated as a
  putative tumor suppressor (attenuating beta-catenin-driven
  epithelial-to-mesenchymal transition and ovarian/glioblastoma progression; in
  ovarian cancer it is down-regulated by MIR937 amplification, stabilizing ULK1)
  and as a negative regulator of NF-kappa-B inflammatory signaling. The protein is
  expressed in several tissues (heart, spleen, colon; tissue-enhanced in
  epididymis and pituitary) and exists as two alternatively spliced isoforms.
alternative_products:
- name: '1'
  id: Q8IX29-1
- name: '2'
  id: Q8IX29-2
  sequence_note: VSP_045600
existing_annotations:
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32296183
  qualifier: enables
  review:
    summary: >-
      Binary interactome (Y2H) interactions of FBXO16 captured by IntAct,
      including LMO1, MORF4L1/MORF4L2, NXT1 and TRIM54. These are real
      interactions but the bare protein binding term is uninformative about
      molecular function.
    action: KEEP_AS_NON_CORE
    reason: >-
      Documents genuine physical interactions recorded by IntAct, but per
      curation guidelines bare protein binding is uninformative and not a core
      molecular function. The functionally meaningful substrate interactions
      (CTNNB1, HNRNPL, RELA, ULK1) come from dedicated studies, not this
      high-throughput screen.
    supported_by:
    - reference_id: file:human/FBXO16/FBXO16-uniprot.txt
      supporting_text: 'Q8IX29; P25800: LMO1; NbExp=3; IntAct=EBI-12063229, EBI-8639312;'
    - reference_id: file:human/FBXO16/FBXO16-uniprot.txt
      supporting_text: 'Q8IX29; Q9UKK6: NXT1; NbExp=5; IntAct=EBI-12063229, EBI-301889;'
- term:
    id: GO:0019005
    label: SCF ubiquitin ligase complex
  evidence_type: NAS
  original_reference_id: PMID:34445249
  qualifier: part_of
  review:
    summary: >-
      FBXO16 is the substrate-recognition (F-box) subunit of an SCF
      (SKP1-CUL1-F-box) E3 ubiquitin ligase complex, as recorded by
      ComplexPortal (CPX-7926, "SCF E3 ubiquitin ligase complex, FBXO16
      variant"). This is the core localization/complex membership of the
      protein.
    action: ACCEPT
    reason: >-
      Core complex membership. FBXO16 contains a bona fide F-box domain
      (residues 86-132) and is annotated by ComplexPortal as the variable
      F-box subunit of an SCF complex; UniProt explicitly states it is part of
      an SCF ligase complex.
    supported_by:
    - reference_id: file:human/FBXO16/FBXO16-uniprot.txt
      supporting_text: >-
        Substrate recognition component of an SCF (SKP1-CUL1-F-box
        protein) E3 ubiquitin-protein ligase complex that mediates the
        ubiquitination and subsequent proteasomal degradation of target
        proteins.
    - reference_id: file:human/FBXO16/FBXO16-uniprot.txt
      supporting_text: 'Part of a SCF (SKP1-cullin-F-box) protein ligase complex.'
- term:
    id: GO:0031146
    label: SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
  evidence_type: NAS
  original_reference_id: PMID:34445249
  qualifier: involved_in
  review:
    summary: >-
      As the substrate receptor of an SCF complex, FBXO16 directs target
      proteins (e.g. nuclear beta-catenin, hnRNPL, RELA, ULK1) into
      SCF-dependent proteasomal degradation. This captures the core biological
      process FBXO16 participates in.
    action: ACCEPT
    reason: >-
      Core biological process. UniProt FUNCTION documents that FBXO16 mediates
      ubiquitination and subsequent proteasomal degradation of multiple
      substrates as the substrate-recognition component of an SCF complex,
      consistent with this SCF-dependent catabolic process term. Falcon-sourced
      primary literature grounds this with multiple validated K48-linked
      substrates (nuclear beta-catenin, hnRNPL, ULK1, nuclear p65/RELA), matching
      the functional placement of FBXO16 as an F-box/SCF (CRL1) substrate-recognition
      receptor.
    supported_by:
    - reference_id: file:human/FBXO16/FBXO16-uniprot.txt
      supporting_text: >-
        Substrate recognition component of an SCF (SKP1-CUL1-F-box
        protein) E3 ubiquitin-protein ligase complex that mediates the
        ubiquitination and subsequent proteasomal degradation of target
        proteins.
    - reference_id: file:human/FBXO16/FBXO16-deep-research-falcon.md
      supporting_text: FBXO16 physically interacts with β-catenin and promotes **K48-linked polyubiquitination** and **proteasome-mediated degradation** of the **nuclear pool** of β-catenin, suppressing Wnt/TCF transcriptional output.
core_functions:
- description: >-
    Substrate-recognition (F-box) component of an SCF/CRL1 E3 ubiquitin ligase
    complex that binds specific substrate proteins (e.g. nuclear
    beta-catenin/CTNNB1, hnRNPL, RELA/p65, ULK1) and presents them, via SKP1 and
    the CUL1-RBX1 catalytic core, for polyubiquitination and proteasomal
    degradation. Acts as a ubiquitin-ligase substrate adaptor rather than the
    catalytic ligase.
  molecular_function:
    id: GO:1990756
    label: ubiquitin-like ligase-substrate adaptor activity
  in_complex:
    id: GO:0019005
    label: SCF ubiquitin ligase complex
  supported_by:
  - reference_id: file:human/FBXO16/FBXO16-uniprot.txt
    supporting_text: >-
      Substrate recognition component of an SCF (SKP1-CUL1-F-box
      protein) E3 ubiquitin-protein ligase complex that mediates the
      ubiquitination and subsequent proteasomal degradation of target
      proteins.
  - reference_id: file:human/FBXO16/FBXO16-uniprot.txt
    supporting_text: 'Part of a SCF (SKP1-cullin-F-box) protein ligase complex.'
  directly_involved_in:
  - id: GO:0031146
    label: SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
proposed_new_terms: []
suggested_questions:
- question: >-
    Which E2 conjugating enzyme and ubiquitin-chain topology does the
    FBXO16-containing SCF complex use across its different substrates, and is
    the K48-linked chain reported for ULK1 a general feature of FBXO16-mediated
    degradation?
- question: >-
    How is FBXO16 substrate selection regulated (e.g. by substrate
    phosphodegron, FBXO16 expression/MIR937 amplification, accessory partners such
    as PDLIM2, or subcellular localization such as the nuclear beta-catenin/p65
    pools), and which substrate relationship is physiologically dominant in a
    given tissue?
- question: >-
    Is FBXO16 a predominantly nuclear CRL1 substrate receptor as the functional
    studies suggest, and does its nuclear localization explain its preference for
    nuclear substrate pools (nuclear beta-catenin, hnRNPL, nuclear p65)?
suggested_experiments:
- description: >-
    Reconstitute the FBXO16-SKP1-CUL1-RBX1 SCF complex in vitro with a defined
    E2 panel and a candidate substrate (e.g. recombinant ULK1, CTNNB1, or hnRNPL)
    to confirm that FBXO16 functions as a substrate adaptor, map the C-terminal
    substrate-binding region, and determine the ubiquitin-chain linkage produced
    on each substrate.
- description: >-
    Perform quantitative ubiquitinome/proteome profiling in FBXO16-knockout
    versus wild-type cells (and with F-box-domain deletion mutants that cannot
    bind SKP1) to define the endogenous substrate repertoire and confirm that
    substrate stabilization requires intact SCF assembly.
- description: >-
    Determine FBXO16 subcellular localization (fractionation, immunofluorescence,
    tagged endogenous knock-in) and test whether nuclear targeting is required for
    degradation of nuclear substrates such as beta-catenin and p65, including the
    contribution of the PDLIM2-containing CRL1 complex.
references:
- id: PMID:32296183
  title: A reference map of the human binary protein interactome.
  findings:
  - statement: >-
      High-throughput yeast two-hybrid binary interactome map that records
      FBXO16 interactions (e.g. LMO1, MORF4L1, MORF4L2, NXT1, TRIM54) deposited
      in IntAct.
    reference_section_type: ABSTRACT
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Full text available. Source of the GO:0005515 bare protein binding
      annotations; high-throughput binary interactome, not FBXO16-specific
      functional characterization.
- id: PMID:34445249
  title: The SCF Complex Is Essential to Maintain Genome and Chromosome Stability.
  findings:
  - statement: >-
      Review of SCF (SKP1-CUL1-F-box) E3 ubiquitin ligase complexes and their
      role in genome/chromosome stability; cited by ComplexPortal as supporting
      reference for SCF complex membership and SCF-dependent proteasomal
      degradation.
    reference_section_type: ABSTRACT
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: >-
      Abstract-only (full_text_available: false). General SCF review used by
      ComplexPortal as the NAS reference for FBXO16's SCF complex membership and
      SCF-dependent catabolic process annotations; supports the family-level
      mechanism rather than FBXO16-specific substrate claims.
- id: file:human/FBXO16/FBXO16-deep-research-falcon.md
  title: Falcon deep research report for human FBXO16
  findings:
  - statement: FBXO16 is a CRL1/SCF substrate-recognition protein that drives K48-linked polyubiquitination and proteasomal degradation of select substrates, with prominent nuclear activity.
    supporting_text: '**FBXO16 is a CRL1/SCF substrate-recognition protein that drives K48-linked polyubiquitination and proteasomal degradation of select substrates, with prominent nuclear activity.**'
  - statement: The FBXO16 F-box domain is required for ligase complex formation while its C-terminal region mediates substrate recognition (e.g. binding the hnRNPL RRM3 domain; C-terminus essential for beta-catenin binding).
    supporting_text: The **F-box domain** is required for **complex formation and ubiquitination function** (e.g., ΔF-box mutants fail to promote ubiquitination of targets or to form productive complexes).
  - statement: FBXO16 targets the nuclear pool of beta-catenin for K48-linked polyubiquitination, suppressing Wnt/TCF transcriptional output.
    supporting_text: FBXO16 physically interacts with β-catenin and promotes **K48-linked polyubiquitination** and **proteasome-mediated degradation** of the **nuclear pool** of β-catenin, suppressing Wnt/TCF transcriptional output.
  - statement: FBXO16 acts as the substrate-recognition component of a PDLIM2-containing CRL1 complex that promotes nuclear p65/RELA polyubiquitination and degradation, limiting NF-kappa-B activation.
    supporting_text: Fbxo16 was identified as a substrate-recognition component in a **PDLIM2-containing CRL1 complex** that promotes p65 polyubiquitination and degradation in nuclear compartments, suppressing NF-κB activation.
  reference_review:
    relevance: HIGH
    correctness: UNVERIFIED
    review_notes: >-
      Falcon synthesis anchored on real primary studies: Khan et al. 2019
      (beta-catenin/glioblastoma), Ji et al. 2021 (hnRNPL/ovarian cancer),
      Zhang et al. 2024 (MIR937/ULK1/autophagy, Cell Death Dis), and
      Sugimoto-Ishige et al. 2025 (p65/PDLIM2-CRL1). These corroborate and extend
      the substrate set already in this review and add a nuclear-localization theme
      and C-terminal substrate-binding domain logic. Falcon cites author-year/DOIs
      not PMIDs and the papers are not in the local cache, so substrate and
      localization claims are treated as strong leads (UNVERIFIED) pending curator
      confirmation; no substrate-specific or nuclear-location GO terms are added on
      this basis alone.
